Physiologic Assessment of Microvascular Function in Heart Transplant Patients

Recruiting now

Conditions studied: Cardiac Allograft Vasculopathy

In brief

The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.

Key facts

Study ID

NCT02798731

Run by

Samsung Medical Center

People needed

200

Starts

2016-05-01

Expected to finish

2030-12-01

Last updated by the study team

2025-03-14

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject over age of 18
• Patients received heart transplant

You may not qualify if…

• Patients with cardiogenic shock
• Patients with unstable vital sign that precludes coronary angiography
• Patients with major bleeding in last 3 months
• Patients with active bleeding
• Patients with coagulopathy
• Patients with severe valvular heart disease
• Patients who refused to provide informed consent

Where it is running

• Samsung Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.